Cor­rect­ed: Fac­ing decades in prison, two biotech lead­ers charged with wire and se­cu­ri­ties fraud, ly­ing to in­ves­ti­ga­tors

Two biotech lead­ers are fac­ing the pos­si­bil­i­ty of decades in prison af­ter a fed­er­al grand ju­ry in Mary­land in­dict­ed them on mul­ti­ple charges re­lat­ed to a scheme to de­fraud in­vestors about the po­ten­tial of the drug leron­limab, a mon­o­clon­al an­ti­body in­ves­ti­ga­tion­al drug al­so known as PRO 140.

Cy­to­Dyn’s for­mer CEO Nad­er Pourhas­san drew at­ten­tion over the last two years for loud­ly tout­ing leron­limab as an ef­fec­tive treat­ment for HIV, can­cer and Covid-19, de­spite clin­i­cal da­ta that in­di­cat­ed the op­po­site.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER